Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q6)Feb 28, 2025 | (FY)Aug 31, 2024 | (Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.43%2.5B | 7.24%1.28B | -0.51%2.37B | 0.25%1.19B | -0.00%2.38B | -1.24%1.19B | 5.39%2.38B | 4.79%1.2B | 11.17%2.26B | -8.86%1.15B |
| Operating income | 5.43%2.5B | 7.24%1.28B | -0.51%2.37B | 0.25%1.19B | -0.00%2.38B | -1.24%1.19B | 5.39%2.38B | 4.79%1.2B | 11.17%2.26B | -8.86%1.15B |
| Cost of sales | 6.72%-1.35B | 14.40%-680.18M | -17.52%-1.45B | -25.95%-794.57M | -28.20%-1.23B | -20.88%-630.84M | -29.93%-961.43M | -38.53%-521.87M | 4.86%-739.96M | 28.64%-376.73M |
| Operating expenses | 6.72%-1.35B | 14.40%-680.18M | -17.52%-1.45B | -25.95%-794.57M | -28.20%-1.23B | -20.88%-630.84M | -29.93%-961.43M | -38.53%-521.87M | 4.86%-739.96M | 28.64%-376.73M |
| Gross profit | 24.57%1.15B | 50.53%597.93M | -19.87%919.66M | -28.80%397.23M | -19.11%1.15B | -18.17%557.92M | -6.56%1.42B | -11.67%681.84M | 21.11%1.52B | 5.39%771.95M |
| Selling expenses | 8.50%-19.7M | 9.57%-16.78M | 13.44%-21.53M | -26.55%-18.56M | 10.83%-24.87M | 23.91%-14.66M | 32.33%-27.89M | 28.22%-19.27M | 11.84%-41.22M | 24.69%-26.85M |
| Administrative expenses | 6.02%-241.43M | -3.94%-158.54M | -28.11%-256.9M | -61.21%-152.53M | -0.85%-200.54M | 8.07%-94.61M | -2.02%-198.85M | 1.76%-102.92M | 2.63%-194.9M | 14.57%-104.77M |
| Impairment and provision | 24.60%-2.23M | 66.15%-1.04M | 55.86%-2.96M | -6.37%-3.07M | -116.38%-6.71M | -235.03%-2.89M | -30.61%-3.1M | 57.66%-862K | 66.98%-2.38M | 40.88%-2.04M |
| -Other impairment is provision | 24.60%-2.23M | 66.15%-1.04M | 55.86%-2.96M | -6.37%-3.07M | -116.38%-6.71M | -235.03%-2.89M | -30.61%-3.1M | 57.66%-862K | 66.98%-2.38M | 40.88%-2.04M |
| Special items of operating profit | 113.03%31.23M | 37.10%-24.25M | -212.99%-239.64M | -129.58%-38.56M | 591.26%212.1M | 2,292.21%130.35M | -108.97%-43.17M | -103.16%-5.95M | 162.43%481.52M | 142.71%188.1M |
| Operating profit | 129.17%913.52M | 115.33%397.31M | -64.65%398.62M | -67.97%184.51M | -1.59%1.13B | 4.21%576.11M | -34.95%1.15B | -33.10%552.83M | 670.81%1.76B | 533.78%826.4M |
| Financing income | -19.39%18.5M | -14.47%11.94M | -52.32%22.95M | -52.78%13.96M | 16.96%48.13M | 58.90%29.57M | 124.38%41.15M | 32.28%18.61M | -34.39%18.34M | -25.75%14.07M |
| Financing cost | 41.27%-33.71M | 16.86%-22.48M | -53.98%-57.4M | -30.64%-27.04M | 38.67%-37.28M | 23.68%-20.7M | 14.69%-60.78M | 38.87%-27.12M | 35.69%-71.25M | 35.50%-44.36M |
| Earning before tax | 146.67%898.31M | 125.61%386.77M | -68.02%364.17M | -70.69%171.44M | 1.09%1.14B | 7.47%584.98M | -34.09%1.13B | -31.63%544.33M | 1,072.63%1.71B | 888.17%796.11M |
| Tax | -9.29%9.5M | -18.99%3.75M | 577.67%10.47M | -1.81%4.62M | -82.15%1.55M | 34.85%4.71M | -0.13%8.65M | -26.64%3.49M | -15.30%8.67M | 7.52%4.76M |
| After-tax profit from continuing operations | 142.32%907.81M | 121.81%390.52M | -67.14%374.64M | -70.14%176.06M | 0.45%1.14B | 7.64%589.69M | -33.91%1.13B | -31.60%547.82M | 1,001.26%1.72B | 842.30%800.87M |
| After-tax profit from non-continuing business | -8.43%26.82M | -12.61%16.85M | --29.28M | --19.28M | ---- | ---- | ---- | ---- | -623.39%-864.64M | --73.33M |
| Earning after tax | 131.39%934.62M | 108.54%407.37M | -64.57%403.92M | -66.87%195.34M | 0.45%1.14B | 7.64%589.69M | 33.09%1.13B | -37.33%547.82M | 165.54%852.78M | 928.58%874.2M |
| Minority shareholders should account for profits from continuing business | -8.43%4.74M | -24.24%1.58M | --5.18M | --2.08M | ---- | ---- | ---- | ---- | -75.91%28.27M | --24.98M |
| Minority profit | -8.43%4.74M | -24.24%1.58M | -3.66%5.18M | -29.13%2.08M | -41.85%5.38M | -46.45%2.94M | -67.28%9.25M | -78.03%5.49M | -75.91%28.27M | -63.13%24.98M |
| Shareholders should account for profits from continuing business | 144.43%903.06M | 123.56%388.94M | --369.46M | --173.98M | ---- | ---- | ---- | ---- | 4,271.72%1.69B | --775.88M |
| Shareholders should account for profits from non-continuing business | -8.43%26.82M | -12.61%16.85M | --29.28M | --19.28M | ---- | ---- | ---- | ---- | -623.39%-864.64M | --73.33M |
| Profit attributable to shareholders | 133.20%929.88M | 109.98%405.79M | -64.86%398.74M | -67.06%193.26M | 0.80%1.13B | 8.19%586.75M | 36.53%1.13B | -36.14%542.33M | 304.49%824.51M | 4,827.85%849.22M |
| Basic earnings per share | 109.09%0.23 | 120.00%0.11 | -65.63%0.11 | -68.75%0.05 | 0.00%0.32 | 0.00%0.16 | 33.33%0.32 | -36.00%0.16 | 300.00%0.24 | 2,400.00%0.25 |
| Diluted earnings per share | 109.09%0.23 | 100.00%0.1 | -54.17%0.11 | -58.33%0.05 | -22.58%0.24 | -20.00%0.12 | 210.00%0.31 | -16.67%0.15 | 66.67%0.1 | 1,700.00%0.18 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.